Maternal mortality across Asia and Oceania reflects a wide range of health systems, economies, geographies, and social conditions. Some countries have achieved major reductions in pregnancy-related deaths, while others continue to face preventable loss during pregnancy, childbirth, and the postpartum period. Regional averages can conceal severe inequalities between urban and rural communities, wealthy and low-income families, and populations with reliable access to skilled care and those living far from hospitals.
The leading causes are frequently treatable when recognized early. Severe bleeding, hypertensive disorders, infection, embolism, and complications from pre-existing disease require fast diagnosis, trained staff, essential medicines, blood products, and dependable referral pathways. Delays at any point can turn a manageable complication into a fatal emergency.
The experience of the COVID-19 pandemic also demonstrated how quickly routine maternity services can be disrupted. Border restrictions, overwhelmed hospitals, staffing shortages, and fear of infection affected antenatal visits and emergency transport. Lessons from that period should inform stronger, more resilient maternal and neonatal care across the region.
Asia contains countries that have made substantial progress in reducing maternal deaths, alongside settings where maternal mortality remains unacceptably high. Improvements often follow expanded antenatal care, wider availability of skilled birth attendants, better immunization and nutrition programs, and increased access to emergency obstetric services. Yet national progress does not guarantee equal protection for every mother.
Remote islands, mountainous districts, conflict-affected areas, and informal settlements face distinctive obstacles. A woman may need to travel for hours before reaching a facility equipped for surgery or transfusion. Transport costs, seasonal weather, language barriers, and limited communication can delay a decision to seek care or prevent a timely referral.
Oceania presents a similar contrast. Australia and New Zealand have advanced specialist services and established maternal death surveillance systems, while some Pacific Island countries contend with small populations, limited specialist coverage, supply-chain constraints, and long distances between islands. Indigenous communities in high-income countries may also experience poorer outcomes because of structural inequality, discrimination, and inadequate continuity of care.
Reliable measurement is the foundation of effective policy. Maternal mortality ratios, usually expressed as maternal deaths per 100,000 live births, allow comparisons over time, but the figures depend on accurate registration and classification. Deaths during pregnancy or after birth can be missed when records are incomplete or when the connection to pregnancy is not documented.
Health authorities should examine more than a single national ratio. Disaggregated data can reveal differences by age, residence, ethnicity, income, migration status, disability, and referral location. Reviews of near-miss cases are equally valuable because women who survive severe hemorrhage or eclampsia can identify weaknesses before another patient dies.
A useful surveillance system combines civil registration, hospital records, confidential inquiries, community reporting, and routine audit. Standard definitions help countries compare findings, while rapid feedback allows hospitals to change protocols quickly. Data should be treated as a clinical tool rather than a reporting exercise completed only for international targets.
| Priority area | Common regional barrier | High-impact response | Useful measure |
|---|---|---|---|
| Antenatal care | Late booking or missed appointments | Community outreach and risk-based follow-up | First-visit timing and continuity |
| Emergency obstetrics | Delayed referral or lack of transport | Regional networks, dispatch systems, and referral protocols | Time from decision to definitive care |
| Hemorrhage response | Limited blood products and inconsistent training | Blood readiness, uterotonics, tranexamic acid, and drills | Severe bleeding case-fatality rate |
| Hypertension | Poor screening or interrupted medication supply | Blood-pressure checks, magnesium sulfate, and escalation pathways | Eclampsia and severe pre-eclampsia rates |
| Postpartum support | Early discharge and weak follow-up | Home visits, hotlines, and danger-sign education | Postpartum review within the first week |
| Accountability | Incomplete cause-of-death classification | Confidential maternal death reviews and action plans | Proportion of recommendations implemented |
Postpartum hemorrhage remains one of the most urgent threats because a woman can deteriorate within minutes. Prevention and treatment require active management of the third stage of labor, rapid recognition of blood loss, uterotonic medicines, intravenous access, tranexamic acid when indicated, blood products, and surgical capacity. Facilities should rehearse these steps so that care does not depend on individual memory during an emergency.
Hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia, demand consistent blood-pressure measurement and clear escalation rules. Aspirin for selected high-risk patients, calcium supplementation where dietary intake is low, magnesium sulfate for seizure prevention or treatment, and timely delivery can save lives. These interventions are effective only when supplies, laboratory support, and trained personnel are available.
Infection, cardiac disease, anemia, diabetes, and thromboembolic conditions also contribute to maternal deaths. As populations become more mobile and chronic disease becomes more common, maternity services must connect obstetric care with primary care, cardiology, hematology, mental health services, and infectious disease expertise. A narrow focus on labor alone misses important risks that begin before conception or continue after delivery.
The three-delay model remains useful for understanding why a woman may not receive care in time. The first delay involves deciding to seek help, often influenced by cost, family authority, misinformation, fear, or previous negative experiences. The second concerns reaching a facility, especially where roads, ambulances, ferries, and communication networks are unreliable. The third occurs inside the health system when triage, diagnosis, treatment, or referral is slow.
Community health workers can reduce the first delay by explaining warning signs and helping families prepare a birth and emergency plan. Antenatal counseling should cover severe headache, visual changes, vaginal bleeding, fever, convulsions, breathing difficulty, reduced fetal movement, and heavy bleeding after birth. Information must be available in local languages and adapted for different literacy levels.
The second and third delays require investment beyond health education. Governments and health networks can establish maternity waiting homes near referral hospitals, coordinate emergency transport, maintain 24-hour blood services, and use teleconsultation to support clinicians in smaller facilities. Standardized referral notes and direct communication between sending and receiving teams prevent patients from arriving without the information or treatment they need.
Respectful care is part of clinical safety. Women are more likely to seek help early when providers listen, protect privacy, explain decisions, and avoid verbal or physical abuse. Midwifery-led continuity models, where appropriate, can strengthen trust while ensuring rapid access to obstetric specialists when complications arise.
Pandemics and natural disasters can interrupt every layer of maternity care. Hospitals may repurpose wards, staff may be reassigned, and patients may avoid facilities because of infection fears. A resilient system identifies maternity services as essential and maintains antenatal appointments, emergency surgery, blood supplies, neonatal support, and postpartum follow-up during a crisis.
Research from the pandemic helped clinicians understand how infection can affect pregnancy, preterm birth, maternal illness, and newborn care. A global pregnancy review illustrates why consistent case definitions and international data sharing are important when evidence develops rapidly. Regional collaboration can help distinguish direct disease effects from harm caused by delayed or unavailable care.
Placental examination may also clarify the pathways linking infection, inflammation, impaired oxygen exchange, and adverse outcomes. The role of placental pathology demonstrates how perinatal research can contribute to clinical understanding beyond the immediate bedside. Hospitals should connect pathology, obstetric, neonatal, and public health data while protecting patient privacy.
Preparedness plans should include personal protective equipment, infection-control training, vaccination access, staff backup, remote consultations, and clear guidance on separation and breastfeeding. These measures protect mothers without unnecessarily separating families or delaying essential newborn care.
Reducing maternal deaths starts before pregnancy. Education, contraception, treatment of anemia, control of chronic disease, and prevention of unintended pregnancy can lower risk. Adolescents and women living with poverty need services that are affordable, confidential, and available without judgment. Preconception counseling is especially important for patients with hypertension, diabetes, kidney disease, heart conditions, or previous obstetric complications.
During pregnancy, every woman should receive risk assessment, evidence-based antenatal care, screening for anemia and hypertension, vaccination, nutrition support, and preparation for birth and emergencies. High-risk patients need coordinated plans rather than disconnected appointments. Referral hospitals should know which patients are coming, what treatments have already been given, and what resources will be required.
The postpartum period deserves equal attention. A normal birth does not eliminate risk, and serious complications can develop after discharge. Follow-up should assess bleeding, blood pressure, infection, wound healing, breastfeeding, mental health, contraception, and newborn wellbeing. Flexible contact through home visits, community clinics, phone services, or telemedicine can be vital where travel is difficult.
Maternal and newborn services should also recognize the family’s wider needs. Substance exposure, poverty, housing instability, and untreated mental illness can affect both mother and infant. Guidance on non-pharmacological neonatal care shows how supportive, family-centered approaches can improve early life care when newborns experience withdrawal or other vulnerabilities.
National strategies should combine clinical quality, social protection, and accountability rather than relying on a single intervention. The following priorities can be adapted to different health systems and levels of available resources:
Partnerships are essential. Ministries of health, professional societies, hospitals, universities, civil-society organizations, and patient advocates can share protocols and training resources while adapting them to local realities. Regional congresses and research networks also provide a space to compare results, strengthen perinatal science, and turn evidence into practical standards.
Progress should be judged by whether women receive timely, respectful, high-quality care—not simply by whether a national average improves. Every preventable death should lead to learning, investment, and measurable change. Health leaders, clinicians, researchers, and communities can act now by strengthening surveillance, funding emergency readiness, and placing women’s experience at the center of maternal care across Asia and Oceania.